Viewing Study NCT00784667


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2025-12-25 @ 10:39 PM
Study NCT ID: NCT00784667
Status: UNKNOWN
Last Update Posted: 2010-11-30
First Post: 2008-11-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib
Sponsor: Austin Health
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module